Get the Stockscreener App
16.27
4.69%
-0.80
Core Laboratories Inc stock is traded at $16.27, with a volume of 325.50K.
It is down -4.69% in the last 24 hours and up +3.17% over the past month.
Core Laboratories Inc is a providers of proprietary and patented reservoir description and production enhancement services and products to the oil and gas industry, through client relationships. The company operates its business in two segments; Reservoir Description, and Production Enhancement. It provides data and analytics to aid well operators in determining optimal methods for recovering, processing, and refining hydrocarbons from a well. It also manufactures the associated lab equipment for its services. The company generates majority of its revenue from Reservoir Description segment.
See More
Previous Close:
$17.07
Open:
$16.97
24h Volume:
325.50K
Relative Volume:
0.85
Market Cap:
$749.21M
Revenue:
$526.52M
Net Income/Loss:
$32.53M
P/E Ratio:
24.09
EPS:
0.6755
Net Cash Flow:
$26.48M
1W Performance:
-5.74%
1M Performance:
+3.17%
6M Performance:
+42.34%
1Y Performance:
+33.91%
1-Day Range:
$16.25
$17.06
1-Week Range:
$16.25
$17.20
52-Week Range:
$9.72
$20.36
Core Laboratories Inc Stock (CLB) Company Profile
Name
Core Laboratories Inc
Sector
Industry
Phone
713-328-2673
Address
6316 WINDFERN ROAD, HOUSTON
Compare CLB vs SLB, BKR, HAL, TS, FTI
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CLB
Core Laboratories Inc
|
16.27 | 760.26M | 526.52M | 32.53M | 26.48M | 0.6755 |
SLB
Slb Ltd
|
51.49 | 77.94B | 35.69B | 3.45B | 4.54B | 2.3617 |
BKR
Baker Hughes Company
|
61.49 | 62.31B | 27.73B | 2.62B | 2.54B | 2.605 |
HAL
Halliburton Co
|
37.51 | 31.39B | 22.18B | 1.29B | 1.67B | 1.5088 |
TS
Tenaris S A Adr
|
58.92 | 30.23B | 12.00B | 1.98B | 2.02B | 3.6742 |
FTI
Technipfmc Plc
|
72.00 | 29.51B | 9.93B | 967.10M | 1.45B | 2.3076 |
Core Laboratories Inc Stock (CLB) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-12-25 | Upgrade | Citigroup | Sell → Neutral |
| Jun-30-23 | Downgrade | Citigroup | Neutral → Sell |
| Apr-18-23 | Downgrade | BofA Securities | Neutral → Underperform |
| Jan-09-23 | Upgrade | BofA Securities | Underperform → Neutral |
| Oct-07-22 | Upgrade | Citigroup | Sell → Neutral |
| Sep-26-22 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Apr-18-22 | Downgrade | Piper Sandler | Neutral → Underweight |
| Oct-18-21 | Downgrade | BofA Securities | Neutral → Underperform |
| Jul-09-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jun-14-21 | Downgrade | Citigroup | Neutral → Sell |
| Dec-18-20 | Downgrade | JP Morgan | Neutral → Underweight |
| Nov-11-20 | Reiterated | Cowen | Market Perform |
| Oct-13-20 | Upgrade | BofA Securities | Underperform → Neutral |
| Sep-29-20 | Upgrade | ABN Amro | Sell → Hold |
| Jul-16-20 | Downgrade | Scotiabank | Sector Outperform → Sector Perform |
| Apr-13-20 | Upgrade | Scotiabank | Sector Perform → Sector Outperform |
| Mar-09-20 | Downgrade | BofA/Merrill | Buy → Underperform |
| Mar-09-20 | Downgrade | Evercore ISI | Outperform → In-line |
| Jan-31-20 | Reiterated | Cowen | Market Perform |
| Jan-30-20 | Resumed | Johnson Rice | Buy |
| Jan-14-20 | Initiated | Bernstein | Mkt Perform |
| Jan-02-20 | Downgrade | Stifel | Buy → Hold |
| Dec-31-19 | Reiterated | Cowen | Market Perform |
| Jul-10-19 | Upgrade | BofA/Merrill | Neutral → Buy |
| Feb-25-19 | Upgrade | Tudor Pickering | Hold → Buy |
| Dec-19-18 | Downgrade | Credit Suisse | Outperform → Neutral |
| Dec-11-18 | Downgrade | JP Morgan | Overweight → Neutral |
| Nov-16-18 | Upgrade | Guggenheim | Neutral → Buy |
| Nov-01-18 | Upgrade | ABN Amro | Sell → Buy |
| Oct-29-18 | Reiterated | Cowen | Market Perform |
View All
Core Laboratories Inc Stock (CLB) Latest News
Retail Surge: Is Core Laboratories Inc part of any major index2026 Rallies & Weekly Breakout Watchlists - baoquankhu1.vn
Update Recap: Will Core Laboratories Inc announce a stock splitQuarterly Risk Review & High Conviction Buy Zone Alerts - baoquankhu1.vn
Insider Sell: Can Core Laboratories Inc be the next market leaderTrade Exit Report & Weekly Top Gainers Trade List - baoquankhu1.vn
Core Laboratories (NYSE:CLB) Updates Q1 2026 Earnings Guidance - MarketBeat
Core Laboratories (CLB) director gains restricted stock and 8,069 shares vest - Stock Titan
Press Releases about Core Laboratories Inc. Common Stock (NYSE:CLB) - FinancialContent
Director at Core Laboratories (NYSE: CLB) gains new share awards - Stock Titan
Core Laboratories (NYSE: CLB) director gets 7,895-share stock grant - Stock Titan
Core Laboratories (NYSE: CLB) director gets 7,895 restricted shares - Stock Titan
Core Laboratories (NYSE: CLB) director receives 7,895 RSUs, 8,069 shares vest - Stock Titan
Core Laboratories (CLB) director receives 7,895 restricted shares and holds 54,397 - Stock Titan
Oilfield Services Stocks Q4 Teardown: Core Laboratories (NYSE:CLB) Vs The Rest - Yahoo Finance
CLB PE Ratio & Valuation, Is CLB Overvalued - Intellectia AI
Core Laboratories (NYSE:CLB) Stock Price Passes Above 200-Day Moving AverageHere's Why - MarketBeat
CLB SEC FilingsCore Laboratories Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Core Laboratories Inc. (CLB) Stock Forecasts - Yahoo! Finance Canada
Core Laboratories : 2025 Annual Report - marketscreener.com
Core Laboratories Inc. (CLB) Stock forecasts - Yahoo Finance UK
Death Cross: Is Core Laboratories Inc likely to announce a buyback2026 Institutional & Stepwise Entry/Exit Trade Alerts - baoquankhu1.vn
Core Laboratories (NYSE: CLB) details 2026 director elections, pay plan and KPMG ratification - Stock Titan
Can Core Laboratories Inc be the next market leaderPortfolio Gains Summary & Risk Controlled Swing Alerts - baoquankhu1.vn
Core Laboratories Hits Day High with Strong 7.25% Intraday Surge - Markets Mojo
Precision Trading with Core Laboratories Inc. (CLB) Risk Zones - Stock Traders Daily
Middle East conflict weighs on Core Laboratories' Q1 outlook - MSN
Zacks Research Brokers Boost Earnings Estimates for CLB - Defense World
Core Laboratories (NYSE:CLB) Trading Up 5.5%Here's Why - MarketBeat
Core Laboratories and Gevo Stocks Trade Up, What You Need To Know - TradingView
Aug Setups: Is Core Laboratories Inc likely to announce a buyback2026 Trading Volume Trends & Technical Entry and Exit Tips - baoquankhu1.vn
Vanguard (NYSE: CLB) amendment shows 0 beneficial shares after realignment - Stock Titan
Core Laboratories: Profit Margins Are Too Small To Get Excited About (NYSE:CLB) - Seeking Alpha
Middle East Tensions Impact Core Laboratories' First Quarter Forecast - Bitget
Core Laboratories Inc stock faces pressure amid oilfield services slowdown and Q4 earnings anticipat - AD HOC NEWS
Middle East Conflict Weighs On Core Laboratories' Q1 Outlook - Yahoo Finance
History Review: Is Core Laboratories Inc backed by strong institutional buying2026 Rallies & Weekly Market Pulse Alerts - baoquankhu1.vn
Core Laboratories (NYSE:CLB) Shares Gap DownHere's Why - MarketBeat
Here’s Why Maintaining a Hold Position Is Suitable for Core Laboratories Shares at This Time - Bitget
Here's Why Hold Strategy Is Apt for Core Laboratories Stock for Now - Yahoo Finance
Core Laboratories Cuts Q1 2026 Guidance Amid Mideast Turmoil - TipRanks
Core Laboratories cuts Q1 2026 guidance on Middle East conflict By Investing.com - Investing.com Australia
Core Lab (CLB) Revises Q1 Revenue Forecast Amid Regional Challen - GuruFocus
Core Laboratories Cuts Q1 Guidance to Account for Middle East Conflict - Moomoo
Stocks to Watch: Core Laboratories, Bark - Moomoo
Core Laboratories (CLB) Shares Drop 4.7% After Lower Q1 Guidance - GuruFocus
Core Labs cuts Q1 guidance, citing impact of Middle East war (CLB:NYSE) - Seeking Alpha
CORE LAB ANNOUNCES IMPACT OF THE MIDDLE EAST CONFLICT TO FIRST QUARTER 2026 GUIDANCE - Bitget
Core Laboratories cuts Q1 2026 guidance on Middle East conflict - Investing.com
Core Laboratories (CLB) Shares Fall 5% Following Preliminary Q1 Results - GuruFocus
Core Laboratories Sees Q1 Adj EPS $0.05-$0.07... - Benzinga
Core Laboratories Expects Q1 2026 Revenue An... - Benzinga
Core revises Q1 2026 guidance, now sees revenue $119M-$123M and EPS $0.05-$0.07 - tradingview.com
Core Laboratories (NYSE: CLB) trims Q1 2026 guidance amid Middle East turmoil - stocktitan.net
Core Laboratories Inc Stock (CLB) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.94%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):